Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NexLife vs Ro

NexLife
Graded #149

Lower grade

vs+11.700000000000003
Ro
Graded #38

Higher grade

The verdict

Ro takes it — 80.2/100 to 68.5/100.

Ro grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A heavyweight platform with brand-name access — but opaque compounded pricing drags its score.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNexLife +2
70
68
Dose & formulationRo +22
64
86
Clinical oversightNexLife +3
89
86
Labs & monitoringRo +29
53
82
FulfillmentRo +17
67
84
Contract termsRo +25
55
80
NexLife · left barRo · right bar

The numbers

MetricNexLifeRo
WeighScore68.5/10080.2/100
GradeCB−
Scorecard rank#149#38
Semaglutide$165/mo (compounded)Not disclosed
Tirzepatide$215/mo (compounded)Not disclosed
CoverageCoverage not publishedMulti-state
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
NexLife

Graded #149 · C

Strengths

  • LegitScript certified platform
  • Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
  • Both semaglutide and tirzepatide at competitive pricing
  • Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset

Where it loses points

  • State availability not publicly disclosed
  • Compounded only — no brand-name options
  • Also covers hormone optimization and longevity
  • Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
Ro

Graded #38 · B−

Strengths

  • Brand-name access + insurance support
  • Oral options
  • Well-funded platform

Where it loses points

  • Does not disclose compounded pricing up front
  • Premium positioning

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard